Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

VEBrant: a multicenter, phase II study of MET inhibitor vebreltinib combined with PD-1-based immunotherapy in advanced clear cell sarcoma.

Future oncology (London, England)·2026

Same author

A modified Delphi consensus on tenosynovial giant cell tumour and giant cell tumour of bone : a report from the Birmingham Orthopaedic Oncology Meeting (BOOM).

The bone & joint journal·2026

Same author

Complications of PI to PIII hemipelvic resections for intermediate and malignant tumours : a systematic review and meta-analysis.

Bone & joint open·2026

Same author

An Adolescent Sacroiliac Spindle Cell Tumor With PDGFB Fusion.

Journal of the National Comprehensive Cancer Network : JNCCN·2026

Same author

Immunotherapy-driven remodeling of the tumor immune microenvironment: Spatiotemporal heterogeneity and multidimensional dynamics.

Biochimica et biophysica acta. Reviews on cancer·2026

Same author

Spatiotemporal controls of neutrophil extracellular traps boosts neutrophils immunotherapy efficiency against solid tumors.

Biomaterials·2026

Search research articles

Related Experiment Video

Updated: Mar 14, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities.

Zhan Wang¹, Binghao Li¹, Yingqing Ren¹

¹Department of Orthopaedics, Centre for Orthopaedic Research, Orthopaedics Research Institute, The Second Affiliated Hospital, Zhejiang University School of Medicine , Hangzhou , China.

Frontiers in Immunology

|September 30, 2016

Summary

Novel T-cell-based adoptive immunotherapies offer promising non-surgical treatment options for osteosarcoma. This review explores combination strategies to enhance T-cell transfer effectiveness for advanced or resistant osteosarcoma cases.

Keywords:

T cell adoptive T cell transfer combination strategy osteosarcoma tumor microenvironment (TMA)

More Related Videos

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Related Experiment Videos

Last Updated: Mar 14, 2026

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Cytotoxic Efficacy of Photodynamic Therapy in Osteosarcoma Cells In Vitro

Published on: March 18, 2014

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells

Published on: May 6, 2018

Area of Science:

Oncology
Immunology
Biomedical Engineering

Background:

Osteosarcoma treatment combining surgery and chemotherapy has limitations, especially for advanced, metastatic, or recurrent cases.
Chemotherapy resistance in advanced osteosarcoma necessitates the development of novel therapeutic strategies.
Adoptive immunotherapy presents a potential non-surgical treatment modality for osteosarcoma.

Purpose of the Study:

To review T-cell-based immunotherapies for osteosarcoma treatment.
To emphasize combination strategies for improving adoptive T-cell transfer efficacy.
To provide a rationale for the clinical development of T-cell-based immunotherapies in osteosarcoma.

Main Methods:

Review of current literature on T-cell-based therapies.
Analysis of naturally occurring and genetically modified T-cell strategies.
Exploration of combination approaches to enhance immunotherapy.

Main Results:

T-cell-based immunotherapies show promise in treating both hematologic malignancies and solid tumors.
Alternative strategies using T cells are being investigated for osteosarcoma.
Combination strategies may significantly improve the effectiveness of adoptive T-cell transfer.

Conclusions:

T-cell-based adoptive immunotherapy is a viable therapeutic avenue for osteosarcoma.
Further research into combination strategies is crucial for optimizing T-cell therapy effectiveness.
Clinical development of T-cell-based immunotherapies is warranted for osteosarcoma patients with limited treatment options.